Daphne Taylor Aptevo Therapeutics Inc. (APVO) insider trading activity

APVO Quotes by TradingView

Daphne Taylor is SVP, CFO of Aptevo Therapeutics Inc.. Currently has a direct ownership of 576 shares of APVO, which is worth approximately $201. The most recent transaction as insider was on Aug 08, 2024, when has been sold 158 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 576
0% 3M change
95.34% 12M change
Total Value Held $201

Daphne Taylor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2024
BUY
Exercise of conversion of derivative security
-
158 Added 21.53%
576 Common Stock
Mar 04 2024
BUY
Exercise of conversion of derivative security
-
1,584 Added 7.92%
18,411 Common Stock
Mar 02 2024
BUY
Exercise of conversion of derivative security
-
3,667 Added 17.89%
16,827 Common Stock
Jan 29 2024
BUY
Exercise of conversion of derivative security
-
792 Added 5.68%
13,160 Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
-
6,945 Added 35.96%
12,368 Common Stock
Mar 04 2023
BUY
Exercise of conversion of derivative security
-
1,583 Added 22.59%
5,423 Common Stock
DT

Daphne Taylor

SVP, CFO
Seattle, WA

Track Institutional and Insider Activities on APVO

Follow Aptevo Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APVO shares.

Notify only if

Insider Trading

Get notified when an Aptevo Therapeutics Inc. insider buys or sells APVO shares.

Notify only if

News

Receive news related to Aptevo Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APVO